Oncolytics Biotech Inc.

Oncolytics Biotech Inc.

ONC.TO
Oncolytics Biotech Inc.CA flagToronto Stock Exchange
1.42
CAD
+0.03
- -
142.25MMarket Cap

Oncolytics Biotech Inc. (ONC.TO) Stock Split History

Learn about Oncolytics Biotech Inc.'s most recent 21-for-200 basis stock split on May 25, 2018. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Oncolytics Biotech Inc.'s most recent stock split

Split Date: 2018-05-25
Split Ratio: 21:200
Price Before Split: $1.06
Price After Split: $0.11

Developer API

Get ONC.TO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ONC.TO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 9.52 times fewer shares (a 21:200 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Oncolytics Biotech Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2018-05-2521:200Yes$1.06$0.11

About Oncolytics Biotech Inc.

Company overview and industry information

Oncolytics Biotech Inc. (ONC.TO) operates in the Biotechnology industry. The recent 21-for-200 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Oncolytics Biotech Inc. Summary

Last updated: 7/8/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.